Tissue-specific alteration of gene expression and function by RU486 and the GeneSwitch system
Maricela Robles-Murguia, Liam C. Hunt, David Finkelstein and 2 more
npj Aging and Mechanisms of Disease · 2019
doi:10.1038/s41514-019-0036-8 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract The GeneSwitch (GS) is a modified Gal4/UAS system, whereby transgene expression is induced in Drosophila by adding the drug RU486 to food. The GS system is routinely used in Drosophila aging and behavioral studies to avoid confounding effects related to genetic background mutations. Here, we report transcriptional and functional defects that are induced by RU486 in a stock- and tissue-dependent manner, such as defects in flight and mitochondrial gene expression. In addition to including proper controls, our findings suggest that context-specific side effects induced by RU486 should be considered in the experimental design and when interpreting the observed phenotypes.
Abstract licence: CC BY-NC-ND
References20
- 14.
- 17.
- 20.
17 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.